SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-221604
Filing Date
2023-08-25
Accepted
2023-08-25 17:09:38
Documents
13
Period of Report
2023-08-25
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d528666d8k.htm   iXBRL 8-K 26816
  Complete submission text file 0001193125-23-221604.txt   190300

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA xoma-20230825.xsd EX-101.SCH 3869
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20230825_def.xml EX-101.DEF 14110
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20230825_lab.xml EX-101.LAB 23494
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20230825_pre.xml EX-101.PRE 15143
7 EXTRACTED XBRL INSTANCE DOCUMENT d528666d8k_htm.xml XML 6649
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 231209220
SIC: 2834 Pharmaceutical Preparations